Bacterin Announces Preliminary Second Quarter Revenue
GlobeNewswire - Thu Jul 09, 3:00PM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary, unaudited revenue for the second quarter of 2015.
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jun 29, 11:45AM CDT
MBI: 6.09 (unch), ASBI: 22.15 (+0.30), CCSC: 4.73 (+0.03), DRNA: 12.61 (+0.31), ERB: 2.13 (-0.01), WSTL: 1.01 (+0.02), DSKX: 3.18 (-0.05), AGO: 25.16 (+0.33), RELV: 1.29 (+0.01), COOL: 1.48 (-0.07), LAYN: 8.50 (+0.18), DCO: 24.34 (+0.12), BPTH: 1.22 (+0.05), BIOS: 3.04 (+0.01), CHNR: 2.15 (+0.04), BBLU: 1.06 (-0.01), MSN: 1.10 (+0.03), SHOS: 9.38 (-0.05)
Bacterin International Holdings & Premier to develop longer term programmes to improve patient care nationwide
M2 - Thu Jun 25, 5:57AM CDT
Biologics products company Bacterin International Holdings (NYSE:MKT:BONE) revealed on Wednesday the launch of a new group purchasing agreement for the Bone Tissue Synthetic Implantable Products Category with Premier.
Bacterin International Holdings, Inc. Awarded Agreement With Premier, Inc.
GlobeNewswire - Wed Jun 24, 6:29AM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE) has been awarded a new group purchasing agreement for the Bone Tissue Synthetic Implantable Products Category with Premier, Inc. Effective July 1st, 2015, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for its members. Bacterin's contracted product portfolio includes OsteoSponge(R), OsteoSelect(R) DBM Putty, OsteoWrap(R), BacFast(R), hMatrix(R) ADM, sports medicine allografts, and traditional allografts.
PINC: 36.92 (+0.90)
Bacterin International Announces Signing of Agreement With Yankee Alliance
GlobeNewswire - Fri Jun 19, 6:29AM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the signing of an agreement with Yankee Alliance, a group purchasing organization (GPO) with more than 11,500 members. The agreement covers Bacterin's complete line of biologic implants, including 3Demin cortical fiber allografts. The contract is a three-year agreement extending through June 2018.
Bacterin Announces the Launch of ArthroFuse(TM)
GlobeNewswire - Wed Jun 03, 6:30AM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the release of ArthroFuse, a patent pending allograft specifically designed for the treatment of hammertoe deformities.
CORRECTING AND REPLACING -- Bacterin Sets Annual Meeting and Record Dates
GlobeNewswire - Fri May 15, 3:00PM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders.
Bacterin Internationals' (BONE) CEO Dan Goldberger on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed May 06, 12:57PM CDT
Bacterin International misses by $0.26, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue May 05, 3:57PM CDT
Bacterin Sets Annual Meeting and Record Dates
GlobeNewswire - Mon May 04, 8:03AM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders.
Bacterin International Receives Coverage From Medicare Administrative Contractor (MAC) for hMatrix(R)
GlobeNewswire - Tue Apr 28, 6:30AM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary allograft, today announced that its Acellular Dermal Matrix allograft (ADM), hMatrix(R), has received coverage from Novitas Solutions, Inc. ("Novitas"
Bacterin to Report First Quarter 2015 Financial Results on May 5, 2015
GlobeNewswire - Thu Apr 23, 3:00PM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended March 31, 2015, on May 5, 2015 at the close of the financial markets.
Bacterin anticipates Q1 2015 revenue in higher USD9.4m - USD9.5m range
M2 - Fri Apr 10, 7:32AM CDT
Bone graft company Bacterin International Holdings (Other OTC:BONE) said on Thursday that it expects its total net revenue in the range of USD9.4m to USD9.5m in the Q1 2015.
Bacterin sees Q1 revenues of ~$9.5M
Seeking Alpha - at Seeking Alpha - Thu Apr 09, 10:21AM CDT
Bacterin Announces Preliminary First Quarter 2015 Results
GlobeNewswire - Thu Apr 09, 9:35AM CDT
Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced preliminary unaudited results for the first quarter of 2015.
Bacterin delisted from NYSE, trading commences on OTCQX
Seeking Alpha - at Seeking Alpha - Thu Apr 09, 8:38AM CDT
OTC Markets Group Welcomes Bacterin International Holdings to OTCQX®
PR Newswire - Thu Apr 09, 8:06AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Bacterin International Holdings, Inc. (OTCQX: BONE), a leader in the development of revolutionary bone graft material, has qualified to trade on OTCQX®, the best marketplace for established, global and growth companies. Bacterin previously traded on the NYSE MKT exchange.
Bacterin International to list its common stock on OTCQX Marketplace
M2 - Thu Apr 09, 6:18AM CDT
Biologics products company Bacterin International Holdings (NYSE MKT:BONE) stated on Wednesday that the trading its common stock on the NYSE MKT will be suspended following NYSE Regulation's suspension notice.
Bacterin International to Begin Trading on OTCQX Marketplace
GlobeNewswire - Wed Apr 08, 7:42PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it received written notice from the staff at NYSE Regulation, Inc. that trading in the company's common stock will be suspended on the NYSE MKT, and the company's common stock will begin trading on the OTCQX(R) marketplace. The suspension notice follows the company's previously announced appeal of NYSE Regulation's delisting determination. Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.